BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 21394103)

  • 21. An inducible cell model for studies of V(D)J recombinational control.
    Sikes ML; Oltz EM
    J Immunol Methods; 1999 Apr; 224(1-2):25-9. PubMed ID: 10357203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.
    Oettinger MA; Schatz DG; Gorka C; Baltimore D
    Science; 1990 Jun; 248(4962):1517-23. PubMed ID: 2360047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATM and p53 are essential in the cell-cycle containment of DNA breaks during V(D)J recombination in vivo.
    Dujka ME; Puebla-Osorio N; Tavana O; Sang M; Zhu C
    Oncogene; 2010 Feb; 29(7):957-65. PubMed ID: 19915617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Footprint analysis of the RAG protein recombination signal sequence complex for V(D)J type recombination.
    Nagawa F; Ishiguro K; Tsuboi A; Yoshida T; Ishikawa A; Takemori T; Otsuka AJ; Sakano H
    Mol Cell Biol; 1998 Jan; 18(1):655-63. PubMed ID: 9418911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA-Rag protein interactions in the control of selective D gene utilization in the TCR beta locus.
    Olaru A; Patterson DN; Villey I; Livák F
    J Immunol; 2003 Oct; 171(7):3605-11. PubMed ID: 14500657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The bounty of RAGs: recombination signal complexes and reaction outcomes.
    Swanson PC
    Immunol Rev; 2004 Aug; 200():90-114. PubMed ID: 15242399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The in vivo pattern of binding of RAG1 and RAG2 to antigen receptor loci.
    Ji Y; Resch W; Corbett E; Yamane A; Casellas R; Schatz DG
    Cell; 2010 Apr; 141(3):419-31. PubMed ID: 20398922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RAG-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.
    Petiniot LK; Weaver Z; Vacchio M; Shen R; Wangsa D; Barlow C; Eckhaus M; Steinberg SM; Wynshaw-Boris A; Ried T; Hodes RJ
    Mol Cell Biol; 2002 May; 22(9):3174-7. PubMed ID: 11940674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional clustering of human RAG2 gene mutations in severe combined immune deficiency.
    Corneo B; Moshous D; Callebaut I; de Chasseval R; Fischer A; de Villartay JP
    J Biol Chem; 2000 Apr; 275(17):12672-5. PubMed ID: 10777560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. V(D)J recombination is not required for the development of lymphoma in p53-deficient mice.
    Nacht M; Jacks T
    Cell Growth Differ; 1998 Feb; 9(2):131-8. PubMed ID: 9486849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA cleavage of a cryptic recombination signal sequence by RAG1 and RAG2. Implications for partial V(H) gene replacement.
    Rahman NS; Godderz LJ; Stray SJ; Capra JD; Rodgers KK
    J Biol Chem; 2006 May; 281(18):12370-80. PubMed ID: 16531612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of CpG methylation on RAG1/RAG2 reactivity: implications of direct and indirect mechanisms for controlling V(D)J cleavage.
    Nakase H; Takahama Y; Akamatsu Y
    EMBO Rep; 2003 Aug; 4(8):774-80. PubMed ID: 12897800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The origins of V(D)J recombination.
    Lewis SM; Wu GE
    Cell; 1997 Jan; 88(2):159-62. PubMed ID: 9008155
    [No Abstract]   [Full Text] [Related]  

  • 34. Joining mutants of RAG1 and RAG2 that demonstrate impaired interactions with the coding-end DNA.
    Nagawa F; Hirose S; Nishizumi H; Nishihara T; Sakano H
    J Biol Chem; 2004 Sep; 279(37):38360-8. PubMed ID: 15249552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints.
    Raghavan SC; Kirsch IR; Lieber MR
    J Biol Chem; 2001 Aug; 276(31):29126-33. PubMed ID: 11390401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Full-length RAG-2, and not full-length RAG-1, specifically suppresses RAG-mediated transposition but not hybrid joint formation or disintegration.
    Swanson PC; Volkmer D; Wang L
    J Biol Chem; 2004 Feb; 279(6):4034-44. PubMed ID: 14612436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An autoregulatory mechanism imposes allosteric control on the V(D)J recombinase by histone H3 methylation.
    Lu C; Ward A; Bettridge J; Liu Y; Desiderio S
    Cell Rep; 2015 Jan; 10(1):29-38. PubMed ID: 25543141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation and Evolution of the RAG Recombinase.
    Teng G; Schatz DG
    Adv Immunol; 2015; 128():1-39. PubMed ID: 26477364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of V(D)J recombination: a dominant role for promoter positioning in gene segment accessibility.
    Sikes ML; Meade A; Tripathi R; Krangel MS; Oltz EM
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12309-14. PubMed ID: 12196630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RAG Chromatin Scanning During V(D)J Recombination and Chromatin Loop Extrusion are Related Processes.
    Lin SG; Ba Z; Alt FW; Zhang Y
    Adv Immunol; 2018; 139():93-135. PubMed ID: 30249335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.